MB Therapeutics expands its leadership team
Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?
Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?
Our team will be at GERPAC 2024 to showcase our innovations in 3D printing for personalized medicine. Come meet us!
Discover the essentials of Good Manufacturing Practices (GMP) for the pharmaceutical industry. Ensure compliance with regulatory quality and safety standards.
What if you had the choice of your medication?
Discover the benefits of pharmaceutical 3D printing of medications for patients.
Find the interview of Sébastien Gallice, president of PREF and pharmacist in one of the largest preparatory pharmacies in France.
Explore how 3D printing offers innovative solutions to reduce waste. Discover the various approaches for a sustainable future.
Discover how pharmaceutical 3D printing of medications offered by MB Therapeutics can improve care for our children.
The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.
Discover how Léna Lemierre, an expert in pharmaceutical 3D printing, is accelerating the development of personalized medicine.
Discover the different 3D printing technologies of pharmaceutical gels to produce personalized medicines.